All PlansAdministrativeLow impact
September 2023 DUR Board Newsletter pdf
Connecticut Medicaid (HUSKY Health)·CT · Cardiology, Internal Medicine, Family Medicine +1 more·Provider Bulletin
We identified it
Jun 20, 2026
Summary
This is a provider education bulletin about dyslipidemia management and nonstatin therapies based on 2022 ACC guidelines. It provides clinical guidance on when to use medications like ezetimibe, PCSK9 monoclonal antibodies, bempedoic acid, and inclisiran for different patient risk groups, but does not announce any billing, coding, or coverage changes.
Action Required
No immediate billing changes required. This is educational content about clinical guidelines for dyslipidemia management. Billing team should be aware that providers may prescribe nonstatin therapies (ezetimibe, PCSK9 inhibitors, bempedoic acid, inclisiran) more frequently based on these guidelines, which may require prior authorizations depending on individual payer policies.